AbbVie Baxter Golden Cross: One Signal Proves Real
Two pharma giants flashed a golden cross this month, but the stories behind AbbVie and Baxter diverge sharply for inc...
ABBV
ABBV tag page highlights three articles on dividend growth, pharma paths, and chart signals to help you judge ABBV's income and risk. See how these insights fit your investment plan.
3 articles
Johnson Johnson AbbVie: Paths to Pharma Dominance
Johnson & Johnson and AbbVie report divergent quarterly results, fueling a debate about two paths to pharma dominance...
Can’t Stop Buying This Dividend Juggernaut: ABBV Growth
A long-time investor explains why AbbVie’s mix of rapidly growing immunology drugs and a dependable dividend keeps dr...